Ultivue launches UltiMapper™ Portfolio of Reagents for Tissue Marker Detection and Analysis at High Level of Multiplexing and Throughput, with Seamless Use in Current Immuno-Histochemistry Workflows

CAMBRIDGE, Mass, July 10, 2018 – Ultivue has announced today the public launch of its UltiMapper™ portfolio of reagents enabling the highest throughput of whole-slide, protein biomarker spatial detection and a...

Read More

Multiplexing in Whole-Slide Tissue Imaging for Life Science

Researchers and clinicians must work across biomarker discovery and companion diagnostic areas to translate the biological complexity of a disease into actionable information. High-content data generation and analysis –...

Read More

Ultivue's Scientific Team Presents Compelling Tissue Marker Multiplexing Data at the American Association for Cancer Research (AACR) Annual Meeting 2018

CAMBRIDGE, Mass, April 16, 2018 – Ultivue has announced today the release of exciting new data illustrating the performance of its proprietary InSituPlex™ technology that powers the company’s reagent offerin...

Read More

Ultivue Inc. Announces Completion of its Series B Financing

CAMBRIDGE, Mass, January 23, 2018--Ultivue, a venture-backed company developing reagent-driven solutions for high-performance biological imaging in situ, has announced today that it has closed a $20 million Series B funding r...

Read More

Ultivue Inc. Launches InSituPlex™ Services for Whole Slide, High Definition Spatial Multiplex Tissue Biomarker Analysis

CAMBRIDGE, Mass, November 9, 2017--Ultivue has announced today the commercial launch of InSituPlex Services that provide transformative interrogation of protein biomarker expression patterns in tissue. The service offering...

Read More

Ultivue Inc. Announces Expansion of Executive Team

CAMBRIDGE, Mass, March 23, 2017--Ultivue has appointed Philippe Mourere as Senior Vice President, Commercial Operations. Mourere previously served as Vice President of Global Sales and Marketing at Cell Signaling Technology a...

Read More

Science Visionaries Add CEO at Ultivue

Unprecedented resolution of microscopic images to change understanding of biology & medicine CAMBRIDGE, Mass, May 2, 2016--Ultivue announced today Dr. Michael J. Natan as its new President and Chief Executive Officer. ...

Read More
News

Ultivue Announces $5.15 Million Series A Financing

CAMBRIDGE, Mass, October 13, 2015--Ultivue, an early stage life sciences tools company, today announced the completion of $5.15 million in Series A financing from a group of investors including ARCH Venture Partners, Hansjoer...

Read More